Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 679

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 679
---
 adjustments Fand H), including the following: EE(i)a One-timespecial bonus and additional severance costs incurred by Kineta upon the Closing of the Mergers in the amount of $971,988 ($1,411,988 total estimate less the $440,000 already incurred during the year ended December 31, 2024); EE(i)bEstimated costs to be incurred by Kineta of $460,955 ($1,188,005 total estimate less the $727,050 already incurred during the year ended December 31, 2024), primarily relating to legal and other professional fees. EE(ii)Estimated costs to be incurred by TuHURA of $3,626,085, consisting of additional transaction-related expenses expected between December 31, 2024 and Closing of the Mergers, primarily relating to printing, legal and other professional fees. As the above costs all represent the estimate of one-timeexpenses directly attributable to the Mergers, and the unaudited pro forma condensed combined statement of operations to give pro forma effect to the Mergers as if the Mergers had occurred on January 1, 2024, all $5,059,028 are presented as adjustments to general and administrative expenses in the unaudited pro forma condensed combined statement of operations for the twelve months ended December 31, 2024. Note 5. Net Loss per Share Net loss per share was first calculated for the already completed Kintara Merger using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Kintara Merger, assuming the shares were outstanding since January 1, 2024, and after giving effect to the 1 for 35 reverse share split effected on October 18th, 2024. As the Kintara Merger is being reflected as if it had occurred at the beginning of the period presented, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Kintara Merger have been outstanding for the entirety of all periods presented. The unaudited pro forma condensed combined financial information has been prepared to present the Kintara Merger for the year ended December 31, 2024 :

|                                                                                   |     | For the Year Ended           
 December 31, 2024 (1)        
 (After share                 
 recapitalization as effected 
 on October 18, 2024)         |             |   |
|:----------------------------------------------------------------------------------|: